Trade Mark Journal No.2026/011 13 March 2026
WO0000001904001 (5)
Office of origin: Republic of Korea
Date of International Registration:19 January 2026
Date of designation in the UK:
19 January 2026

International priority date claimed: 29 July 2025
(Republic of Korea)
(4020250137830)
- Class 5
- Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of inflammatory diseases.
CELLTRION, INC.
Representative: JIDAM IP LAW FIRM, A-201, U Space 2, 670, Deawangpangyo-ro,, Bundang-gu, Seongnam-si, Gyeonggi-do, REPUBLIC OF KOREA